Limit Bleeding Risk in Patients Who Need an Anticoagulant Plus Antiplatelets

April 2017

Debate continues about how to manage patients on an anticoagulant (warfarin, etc) who also need antiplatelet meds (aspirin, etc).

Many patients end up on "triple antithrombotic therapy"...such as warfarin for atrial fib PLUS clopidogrel and aspirin after a stent.

But bleeding risk is high. One in 50 patients will have a serious bleed in the first month of triple therapy...and 1 in 8 in the first year.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote